REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,135,655 | +14.2% | 3,322,488 | 0.0% | 0.85% | +33.9% |
Q2 2023 | $35,151,923 | +7.5% | 3,322,488 | 0.0% | 0.64% | -0.8% |
Q1 2023 | $32,693,282 | -33.1% | 3,322,488 | 0.0% | 0.64% | -31.3% |
Q4 2022 | $48,873,798 | +21.3% | 3,322,488 | 0.0% | 0.94% | +25.0% |
Q3 2022 | $40,302,000 | -13.3% | 3,322,488 | 0.0% | 0.75% | -11.2% |
Q2 2022 | $46,482,000 | -1.8% | 3,322,488 | 0.0% | 0.84% | +9.8% |
Q1 2022 | $47,312,000 | -32.5% | 3,322,488 | 0.0% | 0.77% | -14.9% |
Q4 2021 | $70,071,000 | -19.6% | 3,322,488 | 0.0% | 0.90% | -5.9% |
Q3 2021 | $87,182,000 | -18.4% | 3,322,488 | -3.0% | 0.96% | -11.4% |
Q2 2021 | $106,833,000 | +1.6% | 3,426,325 | 0.0% | 1.08% | +10.0% |
Q1 2021 | $105,154,000 | -10.5% | 3,426,325 | 0.0% | 0.98% | -4.4% |
Q4 2020 | $117,523,000 | +11.5% | 3,426,325 | 0.0% | 1.03% | -22.4% |
Q3 2020 | $105,428,000 | -0.8% | 3,426,325 | 0.0% | 1.32% | -11.4% |
Q2 2020 | $106,285,000 | – | 3,426,325 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
Artal Group S.A. | 700,000 | $6,888 | 0.41% |